title: Erythromycin resistance in viridans streptococci bacteremia is clinically significant.
authors.forename: Eva
authors.initials: E
authors.lastname: Grey
authors.forename: Marianna
authors.initials: M
authors.lastname: Mraz
authors.forename: Andrea
authors.initials: A
authors.lastname: Docze
authors.forename: Jarmila
authors.initials: J
authors.lastname: Korcova
authors.forename: Eva
authors.initials: E
authors.lastname: Bucko
authors.forename: Vladimir
authors.initials: V
authors.lastname: Krcmery
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology*; D024881:Drug Resistance, Bacterial; D004917:Erythromycin / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D010403:Penicillin Resistance; D012307:Risk Factors; D016896:Treatment Outcome; D034363:Viridans Streptococci / Q000187:drug effects* / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents; D004917:Erythromycin